Skip to content
Recall Observatory FDA recall evidence

Device product

MED EL Cochlear Implant System, PULSARci100 Standard - Product Usage: The PULSARci100 Implant is an implantable part of the MED EL Cochlear Implant System and can only be used together with compatible MED EL external components. The MED EL Cochlear Implant System is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.

Z-2138-2019

October 16, 2018

Class II

Product summary

Firm
MED-EL Elektromedizinische Gereate, Gmbh
Event
Event 81683
Status
Terminated
Classification
Class II
Quantity
1 device
Official record key
device-enforcement:Z-2138-2019

Official wording

Reason: Devices were distributed despite the Helium-fine leak test results not being within the cochlear implant standards specification.

Code information: Serial Number 202001

Distribution pattern: Worldwide distribution - US Nationwide in the states of California and Illinois. Countries of ARGENTINA, AUSTRALIA, AUSTRIA, BRAZIL, BULGARIA, CHINA, FRANCE, GEORGIA, KOREA, REPUBLIC OF, POLAND, RUSSIAN FEDERATION, SPAIN, SWEDEN.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Devices were distributed despite the Helium-fine leak test results not being within the cochlear implant standards specification.